| 1/28/2025 | BKHYIG | S&P stabilizes Charles River outlook
|
| 12/13/2024 | BK | Charles River downsizes revolver to $2 billion due in 2029
|
| 6/26/2024 | BKHYIG | S&P goes positive on Charles River
|
| 3/16/2023 | BKBWHYIGLM | Charles River Labs continues lowering leverage through debt repayment
|
| 6/21/2022 | BKHYIG | Fitch gives Charles River loan BBB, notes BBB-
|
| 4/23/2021 | BK | Charles River Labs gets $3 billion amended five-year revolver
|
| 3/9/2021 | BKCVDDEMIGPV | Market Commentary: Primary reasonably busy; secondary firms; Charles River gains; Alcoa in focus
|
| 3/8/2021 | BKCVDDEMIGPV | Market Commentary: Charles River, Alcoa price; forward calendar grows; Playtika holds; Twilio active
|
| 3/8/2021 | BKHY | Moody's assigns Charles River notes Ba2
|
| 3/8/2021 | BKHY | S&P assigns Charles River notes BB
|
| 2/17/2021 | BKBWHY | Charles River leverage to rise from purchase; debt markets considered
|
| 11/20/2020 | BKHY | Moody's upgrades Charles River
|
| 2/11/2020 | BKBWHY | Charles River Labs aims for 3x leverage; debt reduction is a priority
|
| 12/16/2019 | BK | Charles River to use credit facility borrowings to purchase HemaCare
|
| 10/21/2019 | BKHY | Moody’s ups Charles River notes, rates new notes Ba3
|
| 10/21/2019 | BKHY | S&P assigns BB to Charles River bonds
|
| 6/5/2019 | BKBWHYIG | Charles River Labs aims to keep leverage below 3x, but may go higher
|
| 5/1/2019 | BKCVHYIG | S&P lowers Charles River to junk
|
| 2/15/2019 | BK | S&P puts Charles River Labs on watch
|
| 2/14/2019 | BKCVHYIG | S&P puts Charles River on watch
|
| 4/10/2018 | BKCVDDEMIGPV | Market Commentary: Hilton, Silversea upsize; junk market strong; Sprint up on merger news; Tenneco down
|
| 3/29/2018 | BKCVDDEMIGPV | Market Commentary: Ply Gem, Wyndham, W/S price; McDermott delayed; recent deals mixed; funds off $0.62 billion
|
| 3/28/2018 | BKCVDDEMIGPV | Market Commentary: Coty, Charles River price; McDermott widens talk; Tronox trades down; Tesla dominates
|
| 3/26/2018 | BKHYIG | Moody’s ups Charles River loans, rates notes B1
|
| 3/26/2018 | BKHYIG | S&P rates Charles River notes BB+
|
| 3/26/2018 | BK | Charles River refinances credit facilities for upsized $2.3 billion
|
| 2/14/2018 | BK | S&P affirms Charles River
|
| 2/13/2018 | BK | Charles River gets $830 million bridge loan commitment via JPMorgan
|
| 4/5/2016 | BK | Charles River Labs gets $1.65 billion five-year term loan, revolver
|
| 1/12/2016 | BKIG | S&P affirms Charles River, loans
|
| 1/7/2016 | BK | Moody’s: Charles River to stable
|
| 7/9/2015 | BK | Charles River to draw from revolver for $212 million Celsis purchase
|
| 4/28/2015 | BKCV | Moody’s rates Charles River revolver, loan Ba2
|
| 4/24/2015 | BKIG | S&P: Charles River Laboratories facility BBB-
|
| 4/22/2015 | BK | Charles River restates credit facilities to cut pricing, amend maturity
|
| 3/13/2014 | BK | Charles River Laboratories to draw on euro revolver for acquisition
|
| 6/19/2013 | BKCV | Charles River: Q1 sales rise; refinanced credit agreement won't affect capital deployment, says CFO
|
| 6/11/2013 | BKCV | Moody's rates Charles River Laboratories amended loans Ba2
|
| 5/29/2013 | BK | Charles River enters into $970 million restated term loan, revolver
|
| 2/21/2012 | BKCV | Moody's: Charles River to SGL-3
|
| 12/14/2011 | BKCV | Charles River Labs cuts debt in 2011, targets up to $175 million of free cash flow for 2012
|
| 9/26/2011 | BKCV | Moody's rates Charles River loan Ba1
|
| 9/23/2011 | BK | Charles River Laboratories amends $750 million term loan, revolver
|
| 2/24/2011 | BKCV | S&P: Charles River loan BBB-
|
| 2/24/2011 | BKCV | Moody's affirms Charles River
|
| 8/31/2010 | BK | Charles River gets $750 million amended and restated credit facility
|
| 8/27/2010 | BKCV | Moody's rates Charles River loans Ba1
|
| 8/3/2010 | BKCV | Moody's drops Charles River Labs loan
|
| 7/30/2010 | BK | Market Commentary: Savvis, Ntelos break; Warner Chilcott dips; Calpine seesaws; Midcontinent sets spread, adds step
|
| 7/30/2010 | BKCV | Moody's: Charles River unaffected
|
| 6/11/2010 | BK | Market Commentary: Wendy's firm on buyout buzz; Willbros changes expected; Sophos tranching, Telx spread set
|
| 6/10/2010 | BK | Charles River's $1 billion term A expected at Libor plus 275 bps
|
| 6/10/2010 | BK | Market Commentary: TransUnion tweaks deal, breaks; Citgo upsizes; Styron allocating soon; Guardian firms structure
|
| 6/4/2010 | BKCV | Moody's cuts Charles River, rates loans Ba1
|
| 6/4/2010 | BKCV | S&P affirms Charles River, rates loans BBB-
|
| 4/27/2010 | BKCV | Moody's may cut Charles River Labs
|
| 4/26/2010 | BKCV | S&P may cut Charles River
|
| 4/26/2010 | BKCV | S&P may cut Charles River
|
| 4/26/2010 | BK | Charles River plans $1.25 billion credit facility for WuXi purchase
|
| 12/21/2009 | BKCV | Moody's ups Charles River Labs loan
|
| 4/23/2009 | BKCV | S&P: Charles River Labs view stable
|
| 3/12/2009 | BKCV | Moody's: Charles River view negative
|
| 8/11/2008 | BKCV | Moody's cuts Charles River to SGL-2
|
| 3/10/2008 | BKCV | Moody's ups Charles River outlook to stable
|
| 9/29/2006 | BKHY | Moody's introduces new ratings
|
| 8/2/2006 | BKBT | Charles River gets amended and restated credit facility
|
| 6/19/2006 | BKBTCV | S&P assigns Charles River Laboratories convertibles BB-
|
| 5/10/2006 | BKBT | S&P's Charles River Labs ratings unaffected
|
| 2/28/2006 | BKBT | Moody's rates Charles River loans Ba1
|
| 12/22/2005 | BKBT | Charles River amends, restates to layer in new term loans, revolvers
|
| 8/11/2005 | BKBTCV | S&P ups Charles River view to positive
|
| 9/14/2004 | BKCV | Moody's rates Charles River loans Ba1
|
| 7/1/2004 | BK | Charles River $500 million credit facility to come via JPMorgan, CSFB
|
| 2/26/2003 | BK | Moody's raises Alpharma outlook
|
